As of 2025-05-15, the Intrinsic Value of Indoco Remedies Ltd (INDOCO.NS) is 100.85 INR. This INDOCO.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 251.12 INR, the upside of Indoco Remedies Ltd is -59.80%.
The range of the Intrinsic Value is 67.98 - 155.93 INR
Based on its market price of 251.12 INR and our intrinsic valuation, Indoco Remedies Ltd (INDOCO.NS) is overvalued by 59.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 67.98 - 155.93 | 100.85 | -59.8% |
| DCF (Growth 10y) | 113.82 - 224.65 | 155.68 | -38.0% |
| DCF (EBITDA 5y) | 609.67 - 786.46 | 690.89 | 175.1% |
| DCF (EBITDA 10y) | 483.67 - 727.43 | 591.67 | 135.6% |
| Fair Value | -28.84 - -28.84 | -28.84 | -111.49% |
| P/E | (27.76) - 308.30 | 129.19 | -48.6% |
| EV/EBITDA | 197.93 - 605.60 | 372.57 | 48.4% |
| EPV | (2.62) - 21.74 | 9.56 | -96.2% |
| DDM - Stable | (5.09) - (9.60) | (7.34) | -102.9% |
| DDM - Multi | 105.31 - 155.73 | 125.74 | -49.9% |
| Market Cap (mil) | 23,158.29 |
| Beta | 1.21 |
| Outstanding shares (mil) | 92.22 |
| Enterprise Value (mil) | 31,211.09 |
| Market risk premium | 8.31% |
| Cost of Equity | 17.35% |
| Cost of Debt | 13.80% |
| WACC | 15.61% |